131 related articles for article (PubMed ID: 10847236)
1. Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy.
van der Molen EF; Verbruggen B; Nováková I; Eskes TK; Monnens LA; Blom HJ
BJOG; 2000 Jun; 107(6):785-91. PubMed ID: 10847236
[TBL] [Abstract][Full Text] [Related]
2. Clotting disorders and placental abruption: homocysteine--a new risk factor.
Eskes TK
Eur J Obstet Gynecol Reprod Biol; 2001 Apr; 95(2):206-12. PubMed ID: 11301173
[TBL] [Abstract][Full Text] [Related]
3. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene as a new risk factor for placental vasculopathy.
van der Molen EF; Arends GE; Nelen WL; van der Put NJ; Heil SG; Eskes TK; Blom HJ
Am J Obstet Gynecol; 2000 May; 182(5):1258-63. PubMed ID: 10819868
[TBL] [Abstract][Full Text] [Related]
4. Hypercoagulable thrombophilic defects and hyperhomocysteinemia in patients with recurrent pregnancy loss.
Raziel A; Kornberg Y; Friedler S; Schachter M; Sela BA; Ron-El R
Am J Reprod Immunol; 2001 Feb; 45(2):65-71. PubMed ID: 11216876
[TBL] [Abstract][Full Text] [Related]
5. Prediction of ischemic stroke in young Indians: is thrombophilia profiling a way out?
Chatterjee T; Gupta N; Choudhry VP; Behari M; Saxena R; Ashraf MZ
Blood Coagul Fibrinolysis; 2013 Jun; 24(4):449-53. PubMed ID: 23337710
[TBL] [Abstract][Full Text] [Related]
6. Hereditary Thrombophilic Factors in Glaucoma.
Sekeroglu MA; Irkec M; Mocan MC; Orhan M
J Glaucoma; 2016 Feb; 25(2):203-7. PubMed ID: 25264994
[TBL] [Abstract][Full Text] [Related]
7. Maternal cerebral venous thrombosis, uncommon but serious disorder, pathologic predictors and contribution of prothrombotic abnormalities.
Klai S; Fekih-Mrissa N; Mrissa R; Rachdi R; Gritli N
Blood Coagul Fibrinolysis; 2013 Apr; 24(3):269-72. PubMed ID: 23337711
[TBL] [Abstract][Full Text] [Related]
8. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
[TBL] [Abstract][Full Text] [Related]
9. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
[TBL] [Abstract][Full Text] [Related]
10. Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolatereductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis.
Keijzer MB; den Heijer M; Blom HJ; Bos GM; Willems HP; Gerrits WB; Rosendaal FR
Thromb Haemost; 2002 Nov; 88(5):723-8. PubMed ID: 12428084
[TBL] [Abstract][Full Text] [Related]
11. No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene.
Rintelen C; Mannhalter C; Lechner K; Eichinger S; Kyrle PA; Papagiannopoulos M; Schneider B; Pabinger I
Blood Coagul Fibrinolysis; 1999 Mar; 10(2):101-5. PubMed ID: 10192659
[TBL] [Abstract][Full Text] [Related]
12. [Homocysteine, 5,10-methylenetetrahydrofolate reductase and deep venous thrombosis. Survey of 120 patients in internal medicine].
Quéré I; Chassé JF; Dupuy E; Bellet E; Molho-Sabatier P; Tobelem G; Janbon C
Rev Med Interne; 1998 Jan; 19(1):29-33. PubMed ID: 9775112
[TBL] [Abstract][Full Text] [Related]
13. No interaction between factor V Leiden and hyperhomocysteinemia or MTHFR 677TT genotype in venous thrombosis. Results of a meta-analysis of published studies and a large case-only study.
Keijzer MB; Borm GF; Blom HJ; Bos GM; Rosendaal FR; den Heijer M
Thromb Haemost; 2007 Jan; 97(1):32-7. PubMed ID: 17200768
[TBL] [Abstract][Full Text] [Related]
14. Hyperhomocysteinemia and other newly recognized inherited coagulation disorders (factor V Leiden and prothrombin gene mutation) in patients with idiopathic cerebral vein thrombosis.
Ventura P; Cobelli M; Marietta M; Panini R; Rosa MC; Salvioli G
Cerebrovasc Dis; 2004; 17(2-3):153-9. PubMed ID: 14707415
[TBL] [Abstract][Full Text] [Related]
15. Interaction between hyperhomocysteinemia and inherited thrombophilic factors in venous thromboembolism.
De Stefano V; Casorelli I; Rossi E; Zappacosta B; Leone G
Semin Thromb Hemost; 2000; 26(3):305-11. PubMed ID: 11011848
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of hyperhomocysteinaemia, activated protein C resistance and prothrombin gene mutation in inflammatory bowel disease.
Mahmood A; Needham J; Prosser J; Mainwaring J; Trebble T; Mahy G; Ramage J
Eur J Gastroenterol Hepatol; 2005 Jul; 17(7):739-44. PubMed ID: 15947551
[TBL] [Abstract][Full Text] [Related]
17. Association of MTHFR A1298C polymorphism (but not of MTHFR C677T) with elevated homocysteine levels and placental vasculopathies.
Klai S; Fekih-Mrissa N; El Housaini S; Kaabechi N; Nsiri B; Rachdi R; Gritli N
Blood Coagul Fibrinolysis; 2011 Jul; 22(5):374-8. PubMed ID: 21577095
[TBL] [Abstract][Full Text] [Related]
18. Hypercoagulable state and methylenetetrahydrofolate reductase (MTHFR) C677T mutation in patients with beta-thalassemia major in Kuwait.
Mustafa NY; Marouf R; Al-Humood S; Al-Fadhli SM; Mojiminiyi O
Acta Haematol; 2010; 123(1):37-42. PubMed ID: 19940469
[TBL] [Abstract][Full Text] [Related]
19. Thrombophilic predisposition in stroke and venous thromboembolism in Danish patients.
Gaustadnes M; Rüdiger N; Møller J; Rasmussen K; Bjerregaard Larsen T; Ingerslev J
Blood Coagul Fibrinolysis; 1999 Jul; 10(5):251-9. PubMed ID: 10456616
[TBL] [Abstract][Full Text] [Related]
20. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis.
Kluijtmans LA; den Heijer M; Reitsma PH; Heil SG; Blom HJ; Rosendaal FR
Thromb Haemost; 1998 Feb; 79(2):254-8. PubMed ID: 9493571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
